Market Overview:
The global blood and blood components market is expected to reach USD XX million by 2030, at a CAGR of XX% during the forecast period 2018-2030. The market growth is attributed to factors such as rising prevalence of chronic diseases, increasing demand for blood transfusions, and technological advancements in the field of blood transfusion. However, stringent regulatory norms and lack of awareness about donated blood are some factors that may hamper the growth of this market. On the basisof application,the marketis segmentedinto anemia,trauma&surgery,, cancer treatment,, bleeding disorders,, and others. Geographically,the globalmarketis divided into North America,, Latin America,, Europe,,,, Asia Pacific,,,, Middle East & Africa (MEA), with a further analysisof major countries in each region.
Product Definition:
blood: the fluid that circulates in the veins and arteries, carrying nourishment and oxygen to the tissues of the body.
Whole Blood:
Whole blood is the complete blood from a single donor. It is used for transfusions and other medical procedures where patients require large amounts of red blood cells (RBCs), white blood cells (WBCs) or platelets.
Blood Components:
Blood components are the parts of blood that are present in different quantities and types. The main blood components include white cells or leukocytes, platelets, plasma, and red blood cells (RBCs). These play an important role in the body’s immune system.
The global Blood Components.
Application Insights:
Anemia segment held the largest share of the global market in 2017. Anemic patients require regular blood transfusions to improve their health condition. According to WHO, an estimated 563 million people have iron deficiency worldwide and about 150 million suffer from iron deficiency anemia. Thus, increasing number of anemic patients is expected to drive the segment growth during the forecast period.
Trauma & surgery application is projected to witness significant growth over next six years owing to rising incidence of trauma cases globally and especially in developing countries like India and Brazil where road accidents are common occurrence as compared with developed countries like U.S.
Regional Analysis:
North America dominated the global blood and blood components market in 2017. Increasing incidence of cancer, trauma, and road accidents are anticipated to boost the demand for transfusion procedures in this region. According to the American Red Cross, more than half a million people donate blood every day; around 46% of them are volunteers while another 47% are donors who receive compensation for their time.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising healthcare expenditure coupled with increasing awareness about various available alternatives for saving lives during emergency situations like bleeding & shock cases. Moreover, growing medical tourism industry due to low cost treatment in countries like India & China is further expected fuel regional growth over next eight years (2030).
Growth Factors:
- Increasing incidence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. As a result, there is an increased demand for blood and blood components for diagnosis, treatment, and prevention of various chronic diseases.
- Technological advancements in blood transfusion: There have been significant technological advancements in the field of blood transfusion in recent years. These advancements have led to improved safety and efficacy profiles for various blood products. This has resulted in an increase in their demand worldwide.
- Growing awareness about donated blood: There is a growing awareness among people about the importance of donated blood and its role in saving lives. This has led to an increase in the number of people who are willing to donate their Blood & Blood Components globally .
Scope Of The Report
Report Attributes
Report Details
Report Title
Blood and Blood Components Market Research Report
By Type
Whole Blood, Blood Components
By Application
Anemia, Trauma & Surgery, Cancer Treatment, Bleeding Disorders, Others
By Companies
American Association of Blood Banks (AABB), AVIS National, International Federation of Red Cross and Red Crescent Societies (IFRC), NHS Blood and Transplant (NHSBT), Northern Ireland Blood Transfusion Service, Scottish National Blood Transfusion Service(NHS National Services Scotland), Welsh Blood Service
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
199
Number of Tables & Figures
140
Customization Available
Yes, the report can be customized as per your need.
Global Blood and Blood Components Market Report Segments:
The global Blood and Blood Components market is segmented on the basis of:
Types
Whole Blood, Blood Components
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Anemia, Trauma & Surgery, Cancer Treatment, Bleeding Disorders, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- American Association of Blood Banks (AABB)
- AVIS National
- International Federation of Red Cross and Red Crescent Societies (IFRC)
- NHS Blood and Transplant (NHSBT)
- Northern Ireland Blood Transfusion Service
- Scottish National Blood Transfusion Service(NHS National Services Scotland)
- Welsh Blood Service
Highlights of The Blood and Blood Components Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Whole Blood
- Blood Components
- By Application:
- Anemia
- Trauma & Surgery
- Cancer Treatment
- Bleeding Disorders
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Blood and Blood Components Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Blood is composed of red blood cells, white blood cells, and platelets. Blood components include plasma, which is the liquid portion of blood; red blood cells; and platelets.
Some of the major companies in the blood and blood components market are American Association of Blood Banks (AABB), AVIS National, International Federation of Red Cross and Red Crescent Societies (IFRC), NHS Blood and Transplant (NHSBT), Northern Ireland Blood Transfusion Service, Scottish National Blood Transfusion Service(NHS National Services Scotland), Welsh Blood Service.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Blood and Blood Components Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Blood and Blood Components Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Blood and Blood Components Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Blood and Blood Components Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Blood and Blood Components Market Size & Forecast, 2018-2028
4.5.1 Blood and Blood Components Market Size and Y-o-Y Growth
4.5.2 Blood and Blood Components Market Absolute $ Opportunity
Chapter 5 Global Blood and Blood Components Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Blood and Blood Components Market Size Forecast by Type
5.2.1 Whole Blood
5.2.2 Blood Components
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Blood and Blood Components Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Blood and Blood Components Market Size Forecast by Applications
6.2.1 Anemia
6.2.2 Trauma & Surgery
6.2.3 Cancer Treatment
6.2.4 Bleeding Disorders
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Blood and Blood Components Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Blood and Blood Components Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Blood and Blood Components Analysis and Forecast
9.1 Introduction
9.2 North America Blood and Blood Components Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Blood and Blood Components Market Size Forecast by Type
9.6.1 Whole Blood
9.6.2 Blood Components
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Blood and Blood Components Market Size Forecast by Applications
9.10.1 Anemia
9.10.2 Trauma & Surgery
9.10.3 Cancer Treatment
9.10.4 Bleeding Disorders
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Blood and Blood Components Analysis and Forecast
10.1 Introduction
10.2 Europe Blood and Blood Components Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Blood and Blood Components Market Size Forecast by Type
10.6.1 Whole Blood
10.6.2 Blood Components
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Blood and Blood Components Market Size Forecast by Applications
10.10.1 Anemia
10.10.2 Trauma & Surgery
10.10.3 Cancer Treatment
10.10.4 Bleeding Disorders
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Blood and Blood Components Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Blood and Blood Components Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Blood and Blood Components Market Size Forecast by Type
11.6.1 Whole Blood
11.6.2 Blood Components
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Blood and Blood Components Market Size Forecast by Applications
11.10.1 Anemia
11.10.2 Trauma & Surgery
11.10.3 Cancer Treatment
11.10.4 Bleeding Disorders
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Blood and Blood Components Analysis and Forecast
12.1 Introduction
12.2 Latin America Blood and Blood Components Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Blood and Blood Components Market Size Forecast by Type
12.6.1 Whole Blood
12.6.2 Blood Components
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Blood and Blood Components Market Size Forecast by Applications
12.10.1 Anemia
12.10.2 Trauma & Surgery
12.10.3 Cancer Treatment
12.10.4 Bleeding Disorders
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Blood and Blood Components Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Blood and Blood Components Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Blood and Blood Components Market Size Forecast by Type
13.6.1 Whole Blood
13.6.2 Blood Components
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Blood and Blood Components Market Size Forecast by Applications
13.10.1 Anemia
13.10.2 Trauma & Surgery
13.10.3 Cancer Treatment
13.10.4 Bleeding Disorders
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Blood and Blood Components Market: Competitive Dashboard
14.2 Global Blood and Blood Components Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 American Association of Blood Banks (AABB)
14.3.2 AVIS National
14.3.3 International Federation of Red Cross and Red Crescent Societies (IFRC)
14.3.4 NHS Blood and Transplant (NHSBT)
14.3.5 Northern Ireland Blood Transfusion Service
14.3.6 Scottish National Blood Transfusion Service(NHS National Services Scotland)
14.3.7 Welsh Blood Service
